May 10th 2024
This week, new WHO data illustrates challenges during the acute phase of the COVID-19 pandemic, MAD-ID and ACVR conference coverage, and more from Contagion.
Using UV Light to Fight C. difficile in Hospitals
October 13th 2016As hospitals continue to search for new ways to limit their number of patients acquiring Clostridium difficile (C. difficile) infections, a new study shows promise in the use of ultraviolet light technology for ridding patient rooms of highly resistant C. difficile spores.
Read More
Nursing Homes Receive New Rules on Antibiotic Stewardship
October 13th 2016With the use of antibiotics remaining high and steady in American hospitals and healthcare facilities, new rules on infection prevention and antibiotic use are set to bring changes to thousands of nursing homes, nationwide.
Read More
Doctors Discover New Treatment for “Superbug” C. difficile
September 22nd 2016As so-called “superbug” bacteria continue to develop new ways of resisting antibiotics, scientists are on the search for new and alternative treatments. Promising news from a recent study is now showing that we may be able to battle the most virulent strains of the Clostridium difficile bacteria with a class of drugs already on the market.
Read More
Canadian Health Agency Releases 2016 Report on Antibiotic-resistant Bacteria
September 19th 2016When the colistin-resistant gene, mcr-1, was first found in China in 2015, health officials around the world knew that the gene would inevitably appear in their countries. It has since been detected in other parts of Asia, Europe, and North America, including Canada, which just released a 2016 report from their Canadian Antimicrobial Resistance Surveillance System.
Read More
FDA Grants QIDP Designation to MGB-BP-3 to Treat Clostridium difficile-associated Diarrhea
September 12th 2016The FDA has granted biopharmaceutical company, MGB Biopharma’s lead candidate, MGB-BP-3, Qualified Infectious Disease Product (QIDP) designation for the treatment of Clostridium difficile-associated Diarrhea.
Read More
New Genetic Research Holds Promise for C. Difficile Treatment
August 25th 2016In the battle against drug-resistant pathogens, genetic research holds promising answers to our toughest threats. A new study shows that the best tool for treating Clostridium difficile infections could be within the genome of the bacteria itself.
Read More
Probiotics Could Offer Important Line of Defense Against Drug-resistant Bacteria
August 23rd 2016As the rise of antibiotic-resistant bacteria leads to higher rates of life-threatening infections from pathogens such Clostridium difficile and methicillin-resistant Staphylococcus aureus (MRSA), researchers are increasingly looking to probiotic treatment as an important part of fighting infections.
Read More
'Careful Observation' Can Improve Infection Prevention in Healthcare Settings
August 18th 2016Robin Jump, MD, PhD, assistant professor in the Department of Medicine at the Case Western Reserve University, discusses how 'careful observation' can be used to decrease the number of unnecessary antibiotic prescriptions in the healthcare setting.
Watch
Screening and Surveillance of Clostridium difficile in Healthcare Facilities
August 17th 2016Robin Jump, MD, PhD, assistant professor in the Department of Medicine at the Case Western Reserve University, discusses efforts to screen asymptomatic Clostridium difficile carriers as well as some of the barriers to implementing active surveillance and putting asymptomatic carriers in isolation.
Watch
Preventing C. difficile in Post-Acute Care Facilities
August 15th 2016Robin Jump, MD, PhD, assistant professor in the Department of Medicine at the Case Western Reserve University, outlines ways that healthcare providers can improve the prevention and management of C. difficile in post-acute care facilities.
Watch
Are Phage-based Treatments the Solution for C. difficile Infection?
July 4th 2016A new bacteriophage (phage) treatment-based approach to fighting Clostridium difficile (C. difficile) colonization and infection may one day provide for effective treatment against this potentially lethal disease.
Read More
Interfacility Collaboration May Help Prevent Spread of CDI
May 31st 2016Clostridium difficile infection (CDI) can be spread between facilities, particularly in older adults. One study has found that collaboration between facilities may help curb the spread of this potentially deadly infection.
Read More
CDC Calls on Healthcare Professionals to Help Fight Hospital Acquired Infections
March 14th 2016US hospitals have made significant reductions in the incidence of hospital-acquired infections (HAIs) over the past decade, a new report from the Centers for Disease Control and Prevention (CDC) has revealed.
Read More
Increasing Gut Microbial Diversity as a Treatment Plan for Clostridium difficile Infections
February 26th 2016Clostridium difficile infections (CDI) have been a growing source of concern in healthcare as rates of recurrent infections are increasing in elderly populations and widespread antibiotic usage continues.
Read More
Survey Finds US Hospitals Falling Short on Preventing C. Difficile Infection
May 30th 2015A survey of 571 US hospitals regarding practices used to prevent Clostridium difficile infection indicates that nearly half of the facilities appear to not be taking steps to prevent the infection that kills nearly 30,000 people and sickens hundreds of thousands more each year, despite strong evidence that these steps work.
Read More